Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Diaphanospondylodysostosis is characterized by absent ossification of the vertebral bodies and sacrum associated with variable anomalies. It has been described in less than ten patients from different families. Manifestations include a short neck, a short wide thorax, a reduced number of ribs, a narrow pelvis, and inconstant anomalies such as myelomeningocele, cystic kidneys with nephrogenic rests, and cleft palate.
Features include always present findings: Decreased skull ossification, Delayed vertebral ossification, and Absent in utero ossification of vertebral bodies; and common findings: Horseshoe kidney, Increased nuchal translucency, Talipes equinovarus, and Absent fetal nasal bone. 46 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Bones and joints | 5 | Narrow pelvis bone, Delayed vertebral ossification, Absent in utero ossification of vertebral bodies |
BMPER encodes BMP binding endothelial regulator (685 aa). Inhibitor of bone morphogenetic protein (BMP) function, it may regulate BMP responsiveness of osteoblasts and chondrocytes Highest expression in Cells Cultured fibroblasts (18.9 TPM) and Brain Cerebellar Hemisphere (12.3 TPM).
Diaphanospondylodysostosis is associated with mutations in the BMPER gene on chromosome 7.
BMPER is classified as a druggable target (Druggable Genome category) with score 0.0.
Genetic testing for BMPER is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 3 always present features, 4 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for diaphanospondylodysostosis.
2 publications have been identified in PubMed for diaphanospondylodysostosis. Research spans Other (50%) and Case Report / Case Series (50%).
Gregersen PA (2025). [PMID: 39239663](https://pubmed.ncbi.nlm.nih.gov/39239663/). *Clin Genet*. [Case Report / Case Series]
Gofin Y (2025). [PMID: 39972153](https://pubmed.ncbi.nlm.nih.gov/39972153/). *Pediatr Res*. [Other]
Data assembled from 6 of 12 sources · Last updated Sep 19, 2026, 3:00 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Kidneys and urinary system | 5 | Horseshoe kidney, Cystic renal dysplasia, Nephroblastomatosis |
Brain and nerves | 3 | Global developmental delay, Depressed nasal ridge, Depressed nasal bridge |
Lungs and breathing | 3 | Pulmonary hypoplasia, Respiratory distress, Difficulty breathing (respiratory insufficiency) |
Muscles | 2 | Low muscle tone (hypotonia), Generalized hypotonia |
Growth and development | 2 | Disproportionate short-trunk short stature, Intrauterine growth retardation |
Arms and legs | 1 | Hypoplastic fingernail |
Head and neck | 1 | Cleft palate |
Digestive system | 1 | Abnormal liver lobulation |
Pregnancy and birth | 1 | Absent fetal nasal bone |